Literature DB >> 11696351

Characterisation of Rac activation in thrombin- and collagen-stimulated human blood platelets.

C Soulet1, S Gendreau, K Missy, V Benard, M Plantavid, B Payrastre.   

Abstract

In this study, we characterised the mechanisms of Rac GTPase activation in human platelets stimulated by two physiological agonists, either thrombin, acting through membrane receptors coupled to heterotrimeric G-proteins, or collagen which is known to mobilise a tyrosine kinase-dependent pathway. Both agonists induced a rapid activation of Rac that was not significantly affected by the inhibition of integrin alpha(IIb)beta(3) engagement. Using pharmacological inhibitors, we found that phospholipase C activation and calcium mobilisation were essential for platelet Rac activation by either thrombin or collagen whereas protein kinase C inhibition was without effect. In contrast to Rac, Cdc42 activation was independent of phospholipase C activation, indicating that the two GTPases are differently regulated. We also found that phosphoinositide 3-kinase was not required for Rac activation in response to thrombin but was involved in its activation by collagen.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696351     DOI: 10.1016/s0014-5793(01)02984-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Rap1-Rac1 circuits potentiate platelet activation.

Authors:  Lucia Stefanini; Yacine Boulaftali; Timothy D Ouellette; Michael Holinstat; Laurent Désiré; Bertrand Leblond; Patrick Andre; Pamela B Conley; Wolfgang Bergmeier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-10       Impact factor: 8.311

2.  Arf6 plays an early role in platelet activation by collagen and convulxin.

Authors:  Wangsun Choi; Zubair A Karim; Sidney W Whiteheart
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

3.  Regulation of Rac1 and Cdc42 activation in thrombin- and collagen-stimulated CHRF-288-11 cells.

Authors:  Bing Xu; Rajinder P Bhullar
Journal:  Mol Cell Biochem       Date:  2011-03-16       Impact factor: 3.396

4.  The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation.

Authors:  M Keegan Delaney; Junling Liu; Yi Zheng; Michael C Berndt; Xiaoping Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-20       Impact factor: 8.311

5.  Regulation of Rac1 GTPase activity by quinine through G-protein and bitter taste receptor T2R4.

Authors:  Crystal Sidhu; Appalaraju Jaggupilli; Prashen Chelikani; Rajinder P Bhullar
Journal:  Mol Cell Biochem       Date:  2016-11-22       Impact factor: 3.396

6.  Role for the guanine nucleotide exchange factor phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchanger 1 in platelet secretion and aggregation.

Authors:  Feng Qian; Guy C Le Breton; Jia Chen; Jing Deng; John W Christman; Dianqing Wu; Richard D Ye
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-12-29       Impact factor: 8.311

7.  Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway.

Authors:  Panagiotis Flevaris; Zhenyu Li; Guoying Zhang; Yi Zheng; Junling Liu; Xiaoping Du
Journal:  Blood       Date:  2008-10-28       Impact factor: 22.113

8.  Rac1 is essential for phospholipase C-gamma2 activation in platelets.

Authors:  Irina Pleines; Margitta Elvers; Amrei Strehl; Miroslava Pozgajova; David Varga-Szabo; Frauke May; Anna Chrostek-Grashoff; Cord Brakebusch; Bernhard Nieswandt
Journal:  Pflugers Arch       Date:  2008-08-13       Impact factor: 3.657

9.  RhoG protein regulates glycoprotein VI-Fc receptor γ-chain complex-mediated platelet activation and thrombus formation.

Authors:  Soochong Kim; Carol Dangelmaier; Dheeraj Bhavanasi; Shu Meng; Hong Wang; Lawrence E Goldfinger; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2013-10-08       Impact factor: 5.157

Review 10.  Rho GTPases in platelet function.

Authors:  J E Aslan; O J T McCarty
Journal:  J Thromb Haemost       Date:  2013-01       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.